You searched for Antibody candidate - Page 57 of 69

In Depth 2 Nov 2023

How French pharma giant Sanofi is betting big on AI

…two companies agreed to a research and licensing agreement to develop up to 15 small molecule candidates across oncology and immunology, leveraging Exscientia’s end-to-end AI-driven platform utilizing actual patient samples….

November 2, 2023 - 8 minutesmins - By Willow Shah-Neville

autoimmune disease enzyme hansa medical 1

News and Trends 19 Feb 2018

The FDA Backs a Bacterial Enzyme to Treat a Rare Autoimmune Disease

The FDA has awarded Hansa Medical’s lead candidate for the treatment of an autoimmune disease with Orphan Drug Designation, which will support its journey through clinical development. Swedish biotech, Hansa…

February 19, 2018 - 2 minutesmins - By Alex Dale

News and Trends 19 Nov 2020

mRNA Stocks Soar with Final Results of BioNTech’s Covid-19 Vaccine

…over 43,000 volunteers to gauge whether Covid-19 infections could be prevented by a vaccine made out of messenger RNA (mRNA). One group received two doses of the candidate vaccine around…

November 19, 2020 - 6 minutesmins - By Jonathan Smith

More News! 3 Apr 2017

First Treatment for Severe Premenstrual Syndrome Clears Phase II

Swedish Asarina Pharma has announced positive results of a Phase IIa study for the treatment of Premenstrual Dysphoric Disorder (PMDD). With only a single product candidate in its pipeline, Asarina…

April 3, 2017 - 3 minutesmins - By Melanie De Almeida

News and Trends 18 Nov 2022

MIF invests in KAHR to explore lead immunotherapy drug for multiple myeloma

…the investment to explore the potential of DSP107, KAHR’s leading immunotherapy drug candidate for the treatment of multiple myeloma. “We are thrilled to partner with KAHR to help advance DSP107…

November 18, 2022 - 3 minutesmins - By Liza Laws

In Depth 4 Apr 2024

Seven diseases CRISPR technology could cure

…companies in this space, developing off-the-shelf, gene-edited T cell therapies using CRISPR, with two candidates – targeting CD19 and CD70 proteins – in clinical trials. In 2022, the FDA granted…

April 4, 2024 - 11 minutesmins - By Clara Rodríguez Fernández

News and Trends 27 Apr 2016

French Pleodrug for Rare Neurological Disease opens up phase III trial in US

Pharnext is opening their first US study sites for a phase III trial in a rare neuropathy – a milestone in the development of Pharnext’s leading candidate. Based in Paris…

April 27, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 29 Jun 2020

Enterome Secures €46M to Take Microbiome Therapies to Clinical Trials

…candidate therapy — comprising three OncoMimic proteins — into two phase I/II trials. One trial will test the candidate treatment in patients with the aggressive brain cancer glioblastoma and the…

June 29, 2020 - 3 minutesmins - By Helen Albert

News and Trends 11 Mar 2016

Genfit Has Enroled its First Patient in a NASH Phase III Trial

…Genfit, which managed to kickstart a phase III trial for their lead candidate, Elafibranor, just one year after the read-out of the phase IIb results. There is, of course, much…

March 11, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 29 Sep 2016

Boehringer buys a €210M ticket to Virus-based Immuno-Oncology

…compete with other well-known immuno-oncology therapies like CAR-T or TCR. Both companies will collaborate to develop a next-generation platform of oncolytic viruses and advance ViraTherapeutics’ lead candidate, VSV-GP. This candidate…

September 29, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

Expert Advice 17 May 2024

How to use LinkedIn to ace your biotech job search and advance your career

…have the time to do all the candidate research themselves but when they ask for recruiters’ help, they often don’t have the time to train the candidates. There’s no harm…

May 17, 2024 - 12 minutesmins - By Jules Adam

News and Trends 11 Oct 2016

World Mental Health Day: How is Biotech Helping the Cause?

…lead candidate, LMTX, positioning it as one of the most advanced Alzheimer’s treatments. The therapy aims to dissolve the protein aggregates responsible for the disease progression at the molecular level….

October 11, 2016 - 4 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

How French pharma giant Sanofi is betting big on AI

The FDA Backs a Bacterial Enzyme to Treat a Rare Autoimmune Disease

mRNA Stocks Soar with Final Results of BioNTech’s Covid-19 Vaccine

First Treatment for Severe Premenstrual Syndrome Clears Phase II

MIF invests in KAHR to explore lead immunotherapy drug for multiple myeloma

Seven diseases CRISPR technology could cure

French Pleodrug for Rare Neurological Disease opens up phase III trial in US

Enterome Secures €46M to Take Microbiome Therapies to Clinical Trials

Genfit Has Enroled its First Patient in a NASH Phase III Trial

Boehringer buys a €210M ticket to Virus-based Immuno-Oncology

How to use LinkedIn to ace your biotech job search and advance your career

World Mental Health Day: How is Biotech Helping the Cause?

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!